Openbare toegang

Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

J Freeland, M Muñoz, E O’Donnell III, J Langerman, M Darrow, J Bergonio, ...

Clinical Cancer Research 30 (21), 4957-4973, 2024

Mandaten: Howard Hughes Medical Institute

Ergens beschikbaar: 125

[HTML] nejm.org

Mutations associated with acquired resistance to PD-1 blockade in melanoma

JM Zaretsky, A Garcia-Diaz, DS Shin, H Escuin-Ordinas, W Hugo, ...

New England Journal of Medicine 375 (9), 819-829, 2016

Mandaten: US National Institutes of Health

[HTML] nature.com

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

J Lloyd-Price, C Arze, AN Ananthakrishnan, M Schirmer, J Avila-Pacheco, ...

Nature 569 (7758), 655-662, 2019

Mandaten: US National Science Foundation, US Department of Energy, US Department of …

[PDF] cell.com

Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression

A Garcia-Diaz, DS Shin, BH Moreno, J Saco, H Escuin-Ordinas, ...

Cell reports 19 (6), 1189-1201, 2017

Mandaten: US National Institutes of Health

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF (V600E)

PI Poulikakos, Y Persaud, M Janakiraman, X Kong, C Ng, G Moriceau, ...

Nature 480 (7377), 387-390, 2011

Mandaten: US National Institutes of Health

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells

D Rohle, J Popovici-Muller, N Palaskas, S Turcan, C Grommes, ...

Science 340 (6132), 626-630, 2013

Mandaten: US National Institutes of Health, Lymphoma Research Foundation, USA

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations

DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ...

Cancer discovery 7 (2), 188-201, 2017

Mandaten: US National Institutes of Health, V Foundation, USA

[PDF] cell.com

Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress

J Tsoi, L Robert, K Paraiso, C Galvan, KM Sheu, J Lay, DJL Wong, M Atefi, ...

Cancer cell 33 (5), 890-904. e5, 2018

Mandaten: US National Institutes of Health, V Foundation, USA

[PDF] nature.com

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

J Müller, O Krijgsman, J Tsoi, L Robert, W Hugo, C Song, X Kong, ...

Nature communications 5 (1), 5712, 2014

Mandaten: US National Institutes of Health, European Commission, KWF Kankerbestrijding

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF^V600E melanoma

S Hu-Lieskovan, S Mok, B Homet Moreno, J Tsoi, L Robert, L Goedert, ...

Science translational medicine 7 (279), 279ra41-279ra41, 2015

Mandaten: US National Institutes of Health, V Foundation, USA

[PDF] cell.com

Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth

DJ Mulholland, LM Tran, Y Li, H Cai, A Morim, S Wang, S Plaisier, ...

Cancer cell 19 (6), 792-804, 2011

Mandaten: US National Institutes of Health

Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity

Y Kidani, H Elsaesser, MB Hock, L Vergnes, KJ Williams, JP Argus, ...

Nature immunology 14 (5), 489-499, 2013

Mandaten: US National Institutes of Health

[HTML] nature.com

Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor

AS Krall, S Xu, TG Graeber, D Braas, HR Christofk

Nature communications 7 (1), 1-13, 2016

Mandaten: US National Institutes of Health, Damon Runyon Cancer Research Foundation

Type I interferon suppresses type II interferon–triggered human anti-mycobacterial responses

RMB Teles, TG Graeber, SR Krutzik, D Montoya, M Schenk, DJ Lee, ...

Science 339 (6126), 1448-1453, 2013

Mandaten: US National Institutes of Health

[HTML] oup.com

Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures

SB Plaisier, R Taschereau, JA Wong, TG Graeber

Nucleic acids research 38 (17), e169-e169, 2010

Mandaten: US National Institutes of Health

CTLA4 blockade broadens the peripheral T-cell receptor repertoire

L Robert, J Tsoi, X Wang, R Emerson, B Homet, T Chodon, S Mok, ...

Clinical Cancer Research 20 (9), 2424-2432, 2014

Mandaten: US National Institutes of Health

Ibrutinib unmasks critical role of Bruton tyrosine kinase in primary CNS lymphoma

C Grommes, A Pastore, N Palaskas, SS Tang, C Campos, D Schartz, ...

Cancer discovery 7 (9), 1018-1029, 2017

Mandaten: US National Institutes of Health, Lymphoma Research Foundation, USA …

Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma

M Atefi, E Avramis, A Lassen, DJL Wong, L Robert, D Foulad, M Cerniglia, ...

Clinical cancer research 20 (13), 3446-3457, 2014

Mandaten: US National Institutes of Health

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy

S Mok, RC Koya, C Tsui, J Xu, L Robert, L Wu, TG Graeber, BL West, ...

Cancer research 74 (1), 153-161, 2014

Mandaten: US National Institutes of Health

[PDF] cshlp.org